Picture loading failed.

Pre-made Mibavademab biosimilar (Whole mAb, anti-LEPR therapeutic antibody, Anti-CD295/LEPRD/OB-R/OBR Antibody) - benchmark reference antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Order information

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-343-1mg 1mg 3090
GMP-Bios-ab-343-10mg 10mg 21890
GMP-Bios-ab-343-100mg 100mg 148000
GMP-Bios-ab-343-xmg >100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Pre-Made Mibavademab biosimilar, Whole mAb, Anti-LEPR Antibody: Anti-CD295/OB-R/OBR therapeutic antibody
INN Name Mibavademab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2020
Year Recommendedna
CompaniesRegeneron Pharmaceuticals
Conditions Approvedna
Conditions ActiveLipodystrophy
Conditions Discontinuedna
Development Techna